desipramine has been researched along with Brain Disorders in 3 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KRAKOWSKI, AJ | 1 |
| Fogel, BS | 1 |
| Sparadeo, FR | 1 |
| Kardener, SH | 1 |
3 other studies available for desipramine and Brain Disorders
| Article | Year |
|---|---|
TREATMENT OF SEVERE DEPRESSION WITH DESIPRAMINE, A METABOLITE OF IMIPRAMINE.
Topics: Adolescent; Antidepressive Agents; Brain Diseases; Depression; Depressive Disorder; Depressive Disor | 1963 |
Focal cognitive deficits accentuated by depression.
Topics: Adult; Brain Diseases; Brain Injuries; Cognition Disorders; Depressive Disorder; Desipramine; Humans | 1985 |
Acute brain syndrome with florid psychosis from combined desipramine-imipramine therapy.
Topics: Brain Diseases; Desipramine; Humans; Imipramine; Psychoses, Substance-Induced | 1966 |